Otolaryngology and Hearing Disorders
Sensorion focuses on cisplatin-induced hearing loss, with clinical research centered on protecting auditory function in adults exposed to ototoxicity associated with cancer treatment.
- Hearing loss prevention
- Auditory safety
- Ototoxicity mitigation
The sponsor’s research activity in this area reflects a therapeutic interest in preserving inner ear function in patients receiving cisplatin.
Oncology Supportive Care
Its clinical research also addresses treatment-related complications in people with neoplastic disease, with attention to adverse effects that can accompany chemotherapy.
- Cancer-treatment toxicity
- Supportive oncology
- Post-treatment recovery
Trials are directed toward reducing the burden of auditory complications linked to anticancer therapy.
Auditory Protection in Drug-Exposed Populations
Sensorion’s research landscape includes strategies aimed at safeguarding hearing in individuals exposed to ototoxic agents, particularly within the setting of systemic cancer therapy.
- Ototoxic drug exposure
- Sensorineural hearing preservation
- Ear function protection
The therapeutic emphasis remains on preventing damage to the auditory system during and after treatment.
